{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:23:04Z","timestamp":1779114184507,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["82271971"],"award-info":[{"award-number":["82271971"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tianjin Health Science and Technology Project","award":["21JCYBJC01640"],"award-info":[{"award-number":["21JCYBJC01640"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-041A"],"award-info":[{"award-number":["TJYXZDXK-041A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01913-9","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T12:53:09Z","timestamp":1756731189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CT-based deep learning radiomics model for predicting proliferative hepatocellular carcinoma: application in transarterial chemoembolization and radiofrequency ablation"],"prefix":"10.1186","volume":"25","author":[{"given":"Hengtao","family":"Zhang","sequence":"first","affiliation":[]},{"given":"Zhaogang","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Zhongsong","family":"Gao","sequence":"additional","affiliation":[]},{"given":"Zhiwei","family":"Shen","sequence":"additional","affiliation":[]},{"given":"Wen","family":"Shen","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"1913_CR1","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao W, Chen H-D, Yu Y-W, Li N, Chen W-Q. Changing profiles of cancer burden worldwide and in china: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021;134:783\u201391.","journal-title":"Chin Med J (Engl)"},{"key":"1913_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-024-01549-2","volume":"17","author":"K-Y Shen","year":"2024","unstructured":"Shen K-Y, Zhu Y, Xie S-Z, Qin L-X. Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives. J Hematol Oncol. 2024;17:25.","journal-title":"J Hematol Oncol"},{"key":"1913_CR3","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jhep.2019.06.001","volume":"71","author":"J Calderaro","year":"2019","unstructured":"Calderaro J, Ziol M, Paradis V, Zucman-Rossi J. Molecular and histological correlations in liver cancer. J Hepatol. 2019;71:616\u201330.","journal-title":"J Hepatol"},{"key":"1913_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000530495","volume":"12","author":"J Zhou","year":"2023","unstructured":"Zhou J, Sun H, Wang Z, et al. Guidelines for the diagnosis and treatment of primary liver cancer (2022 Edition). Liver Cancer. 2023;12:405\u201344.","journal-title":"Liver Cancer"},{"key":"1913_CR5","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.2147\/JHC.S440636","volume":"10","author":"H-M Li","year":"2023","unstructured":"Li H-M, Huang W, Hu C, Zhang Z-S, Xiao Y-D, Wang T-C. Prognostic factors for patients with proliferative hepatocellular carcinoma after liver resection. J Hepatocell Carcinoma. 2023;10:2059\u201371.","journal-title":"J Hepatocell Carcinoma"},{"key":"1913_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1148\/radiol.2021204352","volume":"300","author":"H-J Kang","year":"2021","unstructured":"Kang H-J, Kim H, Lee DH, et al. Gadoxetate-enhanced MRI features of proliferative hepatocellular carcinoma are prognostic after surgery. Radiology. 2021;300:572\u201382.","journal-title":"Radiology"},{"key":"1913_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76:681\u201393.","journal-title":"J Hepatol"},{"key":"1913_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2147\/JHC.S364742","volume":"9","author":"X Li","year":"2022","unstructured":"Li X, Yao Q, Liu C, et al. Macrotrabecular-massive hepatocellular carcinoma: what should we know? J Hepatocell Carcinoma. 2022;9:379\u201387.","journal-title":"J Hepatocell Carcinoma"},{"key":"1913_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/hep.29762","volume":"68","author":"M Ziol","year":"2018","unstructured":"Ziol M, Pot\u00e9 N, Amaddeo G, et al. Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance. Hepatology (Baltimore MD). 2018;68:103\u201312.","journal-title":"Hepatology (Baltimore MD)"},{"key":"1913_CR10","doi-asserted-by":"publisher","first-page":"e230457","DOI":"10.1148\/radiol.230457","volume":"308","author":"Y Bao","year":"2023","unstructured":"Bao Y, Li J-X, Zhou P, et al. Identifying proliferative hepatocellular carcinoma at pretreatment CT: implications for therapeutic outcomes after transarterial chemoembolization. Radiology. 2023;308:e230457.","journal-title":"Radiology"},{"key":"1913_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13000-021-01106-2","volume":"16","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Murugan P, Li F, Bu L. Needle tract seeding in renal tumor biopsies: experience from a single institution. Diagn Pathol. 2021;16:43.","journal-title":"Diagn Pathol"},{"key":"1913_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1186\/s12967-024-05393-3","volume":"22","author":"G Wang","year":"2024","unstructured":"Wang G, Ding F, Chen K, et al. CT-based radiomics nomogram to predict proliferative hepatocellular carcinoma and explore the tumor microenvironment. J Transl Med. 2024;22:683.","journal-title":"J Transl Med"},{"key":"1913_CR13","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases. Hepatology. 2018;68:723\u201350.","journal-title":"Hepatology"},{"key":"1913_CR14","doi-asserted-by":"publisher","first-page":"6774","DOI":"10.1245\/s10434-022-12000-6","volume":"29","author":"T Chu","year":"2022","unstructured":"Chu T, Zhao C, Zhang J, et al. Application of a convolutional neural network for multitask learning to simultaneously predict microvascular invasion and vessels that encapsulate tumor clusters in hepatocellular carcinoma. Ann Surg Oncol. 2022;29:6774\u201383.","journal-title":"Ann Surg Oncol"},{"key":"1913_CR15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1148\/radiol.2021202553","volume":"298","author":"MR Tomaszewski","year":"2021","unstructured":"Tomaszewski MR, Gillies RJ. The biological meaning of radiomic features. Radiology. 2021;298:505\u201316.","journal-title":"Radiology"},{"key":"1913_CR16","doi-asserted-by":"publisher","first-page":"e230255","DOI":"10.1148\/radiol.230255","volume":"308","author":"M Li","year":"2023","unstructured":"Li M, Fan Y, You H, et al. Dual-energy CT deep learning radiomics to predict macrotrabecular-massive hepatocellular carcinoma. Radiology. 2023;308:e230255.","journal-title":"Radiology"},{"key":"1913_CR17","doi-asserted-by":"publisher","first-page":"101146","DOI":"10.1016\/j.xcrm.2023.101146","volume":"4","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Zhou K, Sun Z, et al. Non-invasive tumor microenvironment evaluation and treatment response prediction in gastric cancer using deep learning radiomics. Cell Rep Med. 2023;4:101146.","journal-title":"Cell Rep Med"},{"key":"1913_CR18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1245\/s10434-007-9733-9","volume":"15","author":"VW-T Lam","year":"2008","unstructured":"Lam VW-T, Ng KK, Chok KS-H, et al. Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: analysis of risk factors and prognostic factors. Ann Surg Oncol. 2008;15:782\u201390.","journal-title":"Ann Surg Oncol"},{"key":"1913_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12880-023-01159-3","volume":"23","author":"H Long","year":"2023","unstructured":"Long H, Wu W, Zhou L, Shen H, Xie X, Liu B. Radiofrequency ablation for pediatric recurrent hepatocellular carcinoma: a single-center experience. BMC Med Imaging. 2023;23:202.","journal-title":"BMC Med Imaging"},{"key":"1913_CR20","doi-asserted-by":"crossref","unstructured":"Morshid A, Elsayes KM, Khalaf AM, et al. A machine learning model to predict hepatocellular carcinoma response to transcatheter arterial chemoembolization. Radiol Artif Intell. 2019;1.","DOI":"10.1148\/ryai.2019180021"},{"key":"1913_CR21","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10278-013-9622-7","volume":"26","author":"K Clark","year":"2013","unstructured":"Clark K, Vendt B, Smith K, et al. The cancer imaging archive (TCIA): maintaining and operating a public information repository. J Digit Imaging. 2013;26:1045\u201357.","journal-title":"J Digit Imaging"},{"key":"1913_CR22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2147\/JHC.S313879","volume":"8","author":"Y Chen","year":"2021","unstructured":"Chen Y, Chen J, Zhang Y, et al. Preoperative prediction of cytokeratin 19 expression for hepatocellular carcinoma with deep learning radiomics based on gadoxetic acid-enhanced magnetic resonance imaging. J Hepatocell Carcinoma. 2021;8:795\u2013808.","journal-title":"J Hepatocell Carcinoma"},{"key":"1913_CR23","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1097\/JS9.0000000000001191","volume":"110","author":"X Li","year":"2024","unstructured":"Li X, Liang X, Li Z, et al. A novel stratification scheme combined with internal arteries in CT imaging for guiding postoperative adjuvant transarterial chemoembolization in hepatocellular carcinoma: a retrospective cohort study. Int J Surg. 2024;110:2556\u201367.","journal-title":"Int J Surg"},{"key":"1913_CR24","doi-asserted-by":"crossref","unstructured":"Zhang W, Li N, Li J, et al. Noninvasive identification of proliferative hepatocellular carcinoma on multiphase dynamic CT: quantitative and LI-RADS lexicon-based evaluation. Eur Radiol. 2025;35:3460\u201375.","DOI":"10.1007\/s00330-024-11247-9"},{"key":"1913_CR25","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1007\/s00330-023-09484-5","volume":"33","author":"L Wang","year":"2023","unstructured":"Wang L, Feng B, Li D, et al. Risk stratification of solitary hepatocellular carcinoma\u2009\u2264\u20095\u00a0cm without microvascular invasion: prognostic values of MR imaging features based on LI-RADS and clinical parameters. Eur Radiol. 2023;33:3592\u2013603.","journal-title":"Eur Radiol"},{"key":"1913_CR26","doi-asserted-by":"crossref","unstructured":"Yan Z, Liu Z, Zhu G, et al. Gadoxetic acid-enhanced MRI-based radiomic models for preoperative risk prediction and prognostic assessment of proliferative HCC. Acad Radiol. 2025;32:157\u201369.","DOI":"10.1016\/j.acra.2024.07.040"},{"key":"1913_CR27","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1007\/s00261-021-02989-x","volume":"46","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Weng S, Li Y, et al. A radiomics nomogram based on contrast-enhanced MRI for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma. Abdom Radiol (NY). 2021;46:3139\u201348.","journal-title":"Abdom Radiol (NY)"},{"key":"1913_CR28","doi-asserted-by":"publisher","first-page":"106609","DOI":"10.1016\/j.cmpb.2021.106609","volume":"215","author":"A Abbasian Ardakani","year":"2022","unstructured":"Abbasian Ardakani A, Bureau NJ, Ciaccio EJ, Acharya UR. Interpretation of radiomics features-A pictorial review. Comput Methods Programs Biomed. 2022;215:106609.","journal-title":"Comput Methods Programs Biomed"},{"key":"1913_CR29","doi-asserted-by":"publisher","first-page":"103068","DOI":"10.1016\/j.critrevonc.2020.103068","volume":"154","author":"M Porcu","year":"2020","unstructured":"Porcu M, Solinas C, Mannelli L, et al. Radiomics and radi-\u2026 omics in cancer immunotherapy: a guide for clinicians. Crit Rev Oncol Hematol. 2020;154:103068.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1913_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41571-021-00560-7","volume":"19","author":"K Bera","year":"2022","unstructured":"Bera K, Braman N, Gupta A, Velcheti V, Madabhushi A. Predicting cancer outcomes with radiomics and artificial intelligence in radiology. Nat Rev Clin Oncol. 2022;19:132\u201346.","journal-title":"Nat Rev Clin Oncol"},{"key":"1913_CR31","first-page":"127","volume":"69","author":"WL Bi","year":"2019","unstructured":"Bi WL, Hosny A, Schabath MB, et al. Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J Clin. 2019;69:127\u201357.","journal-title":"CA Cancer J Clin"},{"key":"1913_CR32","doi-asserted-by":"crossref","unstructured":"Du H, Chen F, Li H, et al. Deep-learning radiomics based on ultrasound can objectively evaluate thyroid nodules and assist in improving the diagnostic level of ultrasound physicians. 2024;14:5932-45.","DOI":"10.21037\/qims-23-1597"},{"key":"1913_CR33","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1097\/JS9.0000000000001213","volume":"110","author":"S Shi","year":"2024","unstructured":"Shi S, Lin C, Zhou J, et al. Development and validation of a deep learning radiomics model with clinical-radiological characteristics for the identification of occult peritoneal metastases in patients with pancreatic ductal adenocarcinoma. Int J Surg (London England). 2024;110:2669\u201378.","journal-title":"Int J Surg (London England)"},{"key":"1913_CR34","doi-asserted-by":"crossref","unstructured":"Gao Q, Zhu H, Dong L, et al. Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma. Cell. 2019;179.","DOI":"10.1016\/j.cell.2019.10.038"},{"key":"1913_CR35","doi-asserted-by":"publisher","first-page":"2199219","DOI":"10.1080\/07853890.2023.2199219","volume":"55","author":"J-X Xu","year":"2023","unstructured":"Xu J-X, Qin S-L, Wei H-W, Chen Y-Y, Peng Y-C, Qi L-N. Prognostic factors and an innovative nomogram model for patients with hepatocellular carcinoma treated with postoperative adjuvant transarterial chemoembolization. Ann Med. 2023;55:2199219.","journal-title":"Ann Med"},{"key":"1913_CR36","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/his.12623","volume":"67","author":"J-P Lai","year":"2015","unstructured":"Lai J-P, Conley A, Knudsen BS, Guindi M. Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinoma. Histopathology. 2015;67:442\u201350.","journal-title":"Histopathology"},{"key":"1913_CR37","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/hep.26526","volume":"58","author":"S Yoshida","year":"2013","unstructured":"Yoshida S, Kornek M, Ikenaga N, et al. Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma. Hepatology (Baltimore MD). 2013;58:1667\u201380.","journal-title":"Hepatology (Baltimore MD)"},{"key":"1913_CR38","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/jmri.29400","volume":"61","author":"M Lu","year":"2025","unstructured":"Lu M, Yan Z, Qu Q, et al. Diagnostic model for proliferative HCC using LI-RADS: assessing therapeutic outcomes in hepatectomy and TKI-ICI combination. J Magn Reson Imaging. 2025;61:134\u201347.","journal-title":"J Magn Reson Imaging"},{"key":"1913_CR39","doi-asserted-by":"crossref","unstructured":"Karim MA, Singal AG, Kum HC, et al. Clinical characteristics and outcomes of nonalcoholic fatty liver disease-associated hepatocellular carcinoma in the United States. Clin Gastroenterol Hepatol. 2023;21.","DOI":"10.1016\/j.cgh.2022.03.010"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01913-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01913-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01913-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T02:31:58Z","timestamp":1757471518000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01913-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1913"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01913-9","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Tianjin First Central Hospital. Written informed consent was waived from each patient due to the retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"363"}}